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ABSTRACT
Wastewater-based epidemiology is an innovative approach that uses the analysis of
human excretion products in wastewater to obtain information about exposure to drugs in
defined population groups. We developed and validated an analytical method for the
simultaneous determination of opioids (morphine, oxycodone, hydrocodone, oxymorphone
and hydromorphone), and cannabinoids (D9-tetrahydrocannabinol, 11-nor-9-carboxy-
tetrahydrocannabinol (THCCOOH) and THCCOOH-glucuronide) in raw-influent wastewater
samples by ultra-high performance liquid chromatography-tandem mass spectrometry.
Method validation included linearity (5–1 000 ng/L for opioids, 10–1 000 ng/L for
cannabinoids), imprecision (<21.2%), accuracy (83%–131%), matrix effect (from –35.1% to
–14.7%) and extraction efficiency (25%–84%), limit of detection (1–5 ng/L) and quantification
(5–10 ng/L) and auto-sampler stability (no loss detected). River and wastewater samples were
collected in triplicate from different locations in New York City and stored at ¡20 C until
analysis. Water from sewage overflow location tested positive for morphine (10.7 ng/L),
oxycodone (4.2–23.5 ng/L), oxymorphone (4.8 ng/L) and hydromorphone (4.2 ng/L). Raw
influent wastewater samples tested positive for morphine (133.0–258.3 ng/L), oxycodone (31.1–
63.6 ng/L), oxymorphone (16.0–56.8 ng/L), hydromorphone (6.8–18.0 ng/L), hydrocodone (4.0–
12.8 ng/L) and THCCOOH (168.2–772.0 ng/L). This method is sensitive and specific for opioids
and marijuana determination in wastewater samples.
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Introduction
Wastewater analysis is the method of choice for deter-
mining what drug(s) are being used in the geographical
areas that wastewater treatment plants service [1]. By
observing human biomarkers in sewage water, analysts
can monitor the consumption of various drugs. These
findings can then be compared to, and even supple-
ment, traditional anonymous surveys. Wastewater epi-
demiology/toxicology is inexpensive, provides virtually
real-time data, and is reliable for assessing the extent
of drug use in a geographical region of interest. Its abil-
ity to rapidly determine drug use trends in an area can
help with the development of targeted public health
programs and policy initiatives in these specific com-
munities. However, some disadvantages of wastewater
analysis include uncertainties because of population
flow variations (e.g. with visitors and tourists), sewage
flow changes, rainfall, and varying inter-individual
drug excretion rates [2,3]. Whereas wastewater analysis
is a rapidly growing field in Europe [4], data for the
evaluation of raw influent wastewater in the United
States (USA) are scarce [2,5]. This type of study has
never been performed in New York City (NYC), which
is the largest city in the USA.
Prescription opioids are used to treat chronic pain,
and their use has increased dramatically in recent
years. This has been strongly associated with increas-
ing rates of nonmedical use of prescription opioids in
the USA [6]. This situation has led to opioids being the
most abused class of prescription drugs [7]. According
to statistics from the New York City Health Depart-
ment, 59 opioid-related deaths occurred in 2000, and
this increased to 220 opioid-related deaths in 2013 [8].
Between 2005 and 2014, the rate of deaths because of
prescription opioid increased 250% (rate of increase
per 100 000 general population). In 2005, prescription
opioids contributed to 29% of the drug overdoses in
New York, and this figure rose to 43% by 2014 [9].
According to the 2014 National Survey on Drug Use
and Health [10], 4.3 million people aged 12 or older
have reported current nonmedical use of prescription
pain relievers.
In the USA, marijuana is the most commonly used
illicit drug, with 22.2 million marijuana users aged 12
or older that have used the drug in the past month
(past-month users) [10]. This is followed by stimulants
(1.6 million past-month users), cocaine (1.5 million
past-month users) and heroin (400 000 past-month
users). Based on National Statistics, 44% of adolescents
12 years and older have used marijuana in their lifetime,
which is about the same percentage as individuals aged
26 and older. Individuals aged 18 to 25 years old have
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the highest percentage of marijuana users (52%) [11].
On July 7 2014, New York became the 23rd state to
legalize medical marijuana [12], allowing medical facili-
ties in eight cities to prescribe capsules, liquids, oils, or
vaporizable forms of cannabis. The effect of marijuana
legalization on prevalence of use is still unknown.
Several authors have published methods for the deter-
mination of licit and illicit drugs in wastewater [13–28].
However, prescription opioid data are scarce, and
wastewater samples have never been analysed
for the major cannabis metabolite in human urine,
11-nor-9-carboxy-tetrahydrocannabinol-glucuronide
(THCCOOH-glucuronide). The objective of this
study was to develop and validate an analytical method
for the detection of morphine, common prescription
opioids (oxycodone, oxymorphone, hydrocodone and
hydromorphone) and cannabinoids in wastewater sam-
ples. Then, for proof of concept, this method was
applied to river water and raw influent wastewater sam-
ples collected from different locations within NYC.
Materials and methods
Reagents and materials
Morphine, oxycodone, hydrocodone, oxymorphone,
hydromorphone, D9-tetrahydrocannabinol (THC) and
its metabolites 11-nor-9-carboxy-tetrahydrocannabinol
(THCCOOH) and THCCOOH-glucuronide were pur-
chased from Cerilliant (Round Rock, TX, USA).
The deuterated analogs THC-d3, THCCOOH-d3,
THCCOOH-glucuronide-d3, morphine-d3, oxycodone-
d6, hydrocodone-d6, oxymorphone-d3 and hydromor-
phone-d6 were also purchased from Cerilliant. Strata
XC 33 mm polymeric strong cation exchange cartridges
of 3 mL/60 mg for calibrators and 6 mL/200 mg for
quality control (QC) and authentic wastewater samples
were purchased from Phenomenex (Torrance, CA,
USA). Ultra-high performance liquid chromatography
(UHPLC) grade methanol, dichloromethane and
ammonium hydroxide were purchased from Pharmco-
Aaper (Brookfield, CT). Isopropanol, liquid chromatog-
raphy mass spectrometry grade acetonitrile, and What-
man glass microfiber filters (outside diameter 4.7 cm,
particle retention 1.6 mm, and thickness 0.26 mm) were
from Thermo Fisher Scientific (Waltham, MA, USA).
Instrumentation
The chromatographic separations were carried out on
an UHPLC–tandem mass spectrometry (MS/MS)
instrument from Shimadzu (Kyoto, Japan). The Nex-
era UHPLC system consisted of a binary LC-20ADXR
high-performance liquid chromatography pump, Nex-
era LC-30AD micro mixer, online degassing unit
(DGU-20A3R) and cooled autosampler (SIL-20SCHT
UFLC). The chromatographic column was a Kinetex
C18 (2.1 mm £ 100 mm, 1.7 mm particle size, 100 A
pore size) and the guard column was a SecurityGuard
ULTRA Cartridges C18(2.1 mm £ 2 mm, Phenom-
enex). Mobile phase A was 0.1% formic acid in water
and mobile phase B was 0.1% formic acid in acetoni-
trile. The following gradient program was used for elu-
tion of cannabinoids: held at 40% B for 4 min,
increased to 95% B and held for 1 min, decreased to
40% B in 0.5 min and held at 40% B for 1.5 min. The
total run time was 7 min and the mobile phase flow
rate was 0.5 mL/min. The following gradient program
was used for elution of opioids: held at 2% B for 1 min,
increased to 30% B in 3 min, increased to 95% B in
2 min and held for 1 min, decreased to 2% B in
0.5 min and held for 2.5 min. The total run time was
10 min and the mobile phase flow rate was 0.3 mL/min.
The column oven was operated at 40 C. The injection
volume was 50 mL for each set of compounds.
The mass spectrometer was a triple quadrupole LC-
MS 8030 from Shimadzu equipped with a dual ioniza-
tion source (atmospheric pressure chemical and elec-
trospray ionization). The nebulizing gas flow was set to
2 L/min, the desolvation line was at 250 C, the heating
block was at 400 C and the drying gas flow was at
15 L/min. The dual ionization source corona needle
voltage and interface voltage were both set to 4.5 kV.
Two multiple reaction monitoring (MRM) transitions
were monitored for each compound (Table 1), with
one used as a quantifier and the other as a qualifier.
Sample preparation
An aliquot (100 mL) of each wastewater sample was
measured using a graduated cylinder and placed in a
beaker, spiked with 50 mL of internal standard mixture
(0.1 mg/mL), and filtered through a glass microfiber fil-
ter. Then, 0.5 mL of HCl was added immediately to
acidify the solution to maximize retention onto mixed-
mode cartridges.
Solid phase extraction
Strata XC 6 mL/200 mg cartridges were conditioned
with 6 mL of methanol and then 6 mL of ultra-high
purity (UHP) water, and 6 mL of 0.1% HCl. Then the
100 mL of acidified wastewater was manually loaded
6 mL at a time (17 times) onto a cartridge with a small
vacuum (<34 473 Pa). The cartridges were washed
with 4 mL of UHP water and 4 mL of 0.1% HCl, and
then dried under vacuum for 15 min. Finally,
8 mL of elution solvent (Vdichloromethane:Visopropanol:
Vammonium hydroxide D 78:20:2) was added. A vacuum
was applied to retrieve all the solvent, and the eluate
was split in half. The opioid samples were labelled set 1,
and the cannabinoid samples were labelled set 2. Each
set was evaporated to dryness under a steady stream of
N2 in a Biotage TurboVap (Uppsala, Sweden) at 40 C.
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The opioid samples (set 1) were reconstituted in 200 mL
of UHP water, and the cannabinoid samples (set 2)
were reconstituted in 200 mL of a mixture (VA:VB D
60:40) of mobile phases A (0.1% formic acid in water)
and B (0.1% formic acid in acetonitrile).
Calibrators, quality controls and internal
standards
An internal standard working solution was prepared by
diluting each ampoule with pure methanol and combin-
ing all analogues to a final concentration of 0.1 mg/mL
in methanol. Standard working solutions were prepared
in pure methanol to a stock concentration of 1 mg/mL,
and then serially diluted to concentrations of 0.1 and
0.01 mg/mL in pure methanol. Calibration working
solution mixtures, containing all compounds of interest,
were also prepared in methanol to concentrations of
0.001, 0.01, 0.1, and 1 mg/mL. These solutions were
used to prepare standard curve solutions at concentra-
tions of 0.5, 1, 3, 5, 10, 50, 100, 500 and 1 000 ng/L.
To reduce the cost and time of this process, calibra-
tors were prepared in 3 mL of UHP water spiked with
the corresponding calibration working solution to
match the amounts of 5 to 1 000 ng/L in 100 mL of
sample. For the calibration curve, clean test tubes were
prepared containing 3 mL of UHP water, 50 mL of
internal standard mixture (0.1 mg/mL), and the follow-
ing volumes of the respective calibrator working
solution: 50 and 100 mL of the 0.01 mg/mL solution
for 5 and 10 ng/L calibrators, 50 and 100 mL of the
0.1 mg/mL solution for 50 and 100 ng/L calibrators,
and 50 and 100 mL of the 1 mg/mL solution for 500
and 1 000 ng/L calibrators. Lastly, 15 mL of HCl (0.5%)
was added before vortex mixing and solid phase
extraction (SPE). Strata XC 3 mL/60 mg cartridges
were conditioned with 3 mL of methanol, followed by
3 mL of UHP water and 3 mL of 0.1% HCl. The acidi-
fied calibrator was loaded onto the mixed-mode car-
tridge. Cartridges were washed with 2 mL of UHP
water and 2 mL of 0.1% HCl, and then dried under
vacuum for 15 min. Sample elution was performed
with 4 mL of a dichloromethane/isopropanol/ammo-
nium hydroxide mixture (Vdichloromethane:Visopropanol:
Vammonium hydroxide D 78:20:2). The eluate was split in
half. The samples were labelled as set 1 for opioids and
set 2 for cannabinoids. Each set was evaporated to dry-
ness under a steady stream of N2 in a Biotage Turbo-
Vap at 40 C. Opioid samples (set 1) were reconstituted
in 200 mL of UHP water, and cannabinoids samples
(set 2) were reconstituted in 200 mL of a mixture
(VA:VB D 60:40) of mobile phases A (0.1% formic acid
in water) and B (0.1% formic acid in acetonitrile).
QC samples were prepared at 10 and 100 ng/L by
spiking 100 mL of UHP water with the required
amount of the working solution and 50 mL of the inter-
nal standard mixture. These samples were then filtered,
and 0.5 mL of HCl (0.5% HCl) was added before SPE.
Sample collection
For proof of concept, 33 samples were collected from
river water (22 samples), sewage overflow (6 samples)
and raw influent from wastewater treatment plants
(5 samples) in NYC. River samples were collected from
the Hudson and East Rivers in the Bronx, Manhattan,
Queens and Roosevelt Island. Sewage overflow samples
were collected from Newtown Creek (Brooklyn), and
wastewater samples were collected from the Tallman
and Jamaica wastewater treatment plants in Queens.
Samples were collected for 1–3 days before and after
national holidays (Independence Day, July 4 2015;
Labor Day, September 7 2015; New Year’s Day, January
1 2016) and on March 25th and 30th 2016. The sam-
ples were collected at one time on each of these days
(between 7 and 11 am) in 200 mL NalgeneTM Certified
Wide-Mouth Amber high-density polyurethane bottles
(Thermo Fisher Scientific). To prevent degradation of
the target drugs, the samples were stored in a freezer at
–20 C until required for analysis.
Table 1. Multiple reaction monitoring transitions, retention time (RT) and precursor ion for each analyte of interest.
Compound RT (min)
Precursor ion
(m/z)
Quantifier product
ion (m/z)
Collision energy1)
(eV)
Qualifier product
ion (m/z)
Collision energy2)
(eV)
Morphine 3.14 286 165 ¡40 181 ¡33
Morphine-d3 3.13 289 164 ¡44 153 ¡43
Hydromorphone 3.44 286 184 ¡33 157 ¡43
Hydromorphone-d6 3.42 292 185 ¡33 157 ¡49
Oxymorphone 3.29 302 226 ¡32 242 ¡28
Oxymorphone-d3 3.29 304 201 ¡45 230 ¡31
Oxycodone 3.98 316 256 ¡26 212 ¡46
Oxycodone-d6 3.97 322 247 ¡31 262 ¡29
Hydrocodone 4.10 300 199 ¡31 170 ¡40
Hydrocodone-d6 4.08 306 202 ¡36 174 ¡44
THC 4.01 315 193 ¡23 122 ¡38
THC-d3 4.00 318 195 ¡27 122 ¡39
THCCOOH 2.87 345 299 ¡21 192 ¡28
THCCOOH-d3 2.86 348 330 ¡17 302 ¡23
THCCOOH-glucuronide 1.98 521 345 ¡15 326 ¡18
THCCOOH-glucunoride-d3 1.94 524 348 ¡15 330 ¡21
1)Collision energy for Quantifier production.
2)Collision energy for Qualifier production.
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Validation parameters
The method was validated using various procedures
outlined by the Scientific Working Group for Forensic
Toxicology guidelines [29] for the linearity, limit of
detection (LOD), limit of quantification (LOQ), inter-
ferences (specificity), autosampler stability, impreci-
sion, accuracy, carryover, extraction efficiency, process
efficiency and matrix effect.
Linearity was determined over five different days by
least-squares regression and different weighting factors
(none, 1/x and 1/x2) were evaluated. The linearity was
acceptable if the coefficient of determination (R2) was
 0.99 and the residuals were within §20%. The LOD
and the LOQ were evaluated with decreasing analyte
concentrations in spiked samples from three different
sources. The LOD was the lowest concentration with
acceptable chromatographic parameters, a signal-to-
noise ratio > 3, the presence of all product ions, the
correct ion ratio (within §20% from the average of the
calibrators) and a suitable retention time (within
§0.2 min of the retention time of the calibrators). The
LOQ satisfied the LOD criteria and was quantified
within §20% imprecision and 80%–120% accuracy.
Interferences from matrix components were evalu-
ated by analysing river (nD 22) and wastewater (nD 4)
samples negative for the compounds of interest, after
spiking with the internal standard solution. Interfer-
ences were considered insignificant if the analytes of
interest were not detected in these samples. Method
specificity was demonstrated by analysing high concen-
trations (1 000 ng/L) of potentially interfering drugs.
The following compounds and their metabolites
were examined: opioids (morphine-3-glucuronide,
morphine-6-glucuronide, hydromorphone-3-glucuro-
nide, oxymorphone-3-glucuronide, oxymorphone-
6-glucuronide and 6-acetylmorphine), cannabinoids
(11-hydroxy-THC, cannabinol, and cannabidiol) and
common drugs of abuse (cocaine, benzoylecgonine,
amphetamine, methamphetamine, 3,4-methylenediox-
yamphetamine, 3,4-methylenedioxymethamphetamine
and methadone). Sufficient specificity was achieved if
the analytes of interest were below the LOD.
To determine carryover, blank samples spiked
with the internal standard (negative calibrator)
were injected immediately after samples spiked at
2 000 ng/L (twice the highest calibrator concentration).
The carryover was considered negligible if the mea-
sured concentration was less than the LOD. Before
SPE, the 2 000 ng/L samples were prepared using 3 mL
of UHP water and spiking it with 50 mL of internal
standard, 200 mL of the 1 mg/mL calibrator solution
and 15 mL of HCl.
Inter- and intra-day QC samples at 10 ng/L and
100 ng/L were prepared in 100 mL of UHP water
spiked with 100 mL of the 0.01 mg/mL solution (for
10 ng/L concentration) or the 0.1 mg/mL solution
(for 100 ng/L concentration). The imprecision and
accuracy were determined at these two concentrations
with four repeat analyses on one day (intra-day n D 4)
and over five days (inter-day n D 5). The imprecision
was determined using the coefficient of variation of the
measured values and expected to be less than 20%. The
intra- and inter-day imprecision were calculated as the
standard deviation of the QC concentrations £ 100/
mean QC concentrations. The accuracy was calculated
as a percentage of the target concentration, and was
required to be within 80%–120%. The intra- and inter-
day accuracy was calculated as the mean QC concen-
trations £ 100/QC target concentration.
Autosampler stability was evaluated by reinjecting
four QC samples after 24 h in the autosampler at
10 C. The QC samples were prepared at 10 ng/L using
100 mL of UHP water and 100 mL of 0.01 mg/mL cali-
brator working solution. The concentrations within
§20% of the initial concentration were considered
acceptable.
To evaluate the matrix effect, extraction efficiency
and process efficiency, three sets of samples were
prepared in duplicate at the same concentration
(10 ng/L). Set 1 contained neat samples prepared by
adding 2 mL of elution solvent, 50 mL of internal stan-
dard, and 100 mL of the 0.01 mg/mL solution to a clean
test tube. This sample was then split equally, evapo-
rated to dryness and reconstituted in the appropriate
opioid or cannabis mobile phase for LC-MS/MS sepa-
ration and analysis. Set 2 contained QC samples spiked
at 10 ng/L with the internal standard and submitted to
the same sample preparation and extraction steps as
above. Set 3 contained QC samples spiked at 10 ng/L
and with the internal standard post-extraction. The
samples were from four different sources, including
samples prepared with UHP water (one set) and using
authentic wastewater samples that tested negative for
the target drugs (three sets). The peak areas for Set 1
and 3 were compared to determine if there were any
matrix effects. The peak areas for the Set 2 and 3 sam-
ples were compared to assess the extraction efficiency,
and those for Set 1 and Set 2 were used to assess the
process efficiency.
Identification criteria
The identification criteria included a retention time
within §0.2 min of the calibrator retention time, the
presence of two product ions (quantitative and qualita-
tive) and an ion ratio within §20% from the average of
the calibrators.
Results
Method validation
The LOQ and LOD for all opioids were 5 and 1 ng/L,
respectively, and the linear range was 5–1 000 ng/L.
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For the cannabinoids, the LOQ, LOD and linear range
were 10, 5 and 10–1 000 ng/L, respectively. Acceptable
linearity for opioids and cannabinoids (R2  0.99 and
residuals within §20%) were achieved with 1/x2
weighting. No endogenous or exogenous interferences
were detected.
For opioids, the intra- and inter-day imprecision
were 3.3% to 14.1%, respectively, and the accuracy was
93.3%–131.0%. For cannabinoids, the intra and inter-
day imprecision were 4.1% to 21.2%, respectively, and
the accuracy was 83.0% to 119.3%. For opioids, the
extraction efficiency range was 75.0%–84.0%, and the
process efficiency range from 63.1% to 73.3%. For can-
nabinoids, the extraction efficiency range was 25.4%–
66.5% and the process efficiency range was 22.7%–
62.7%. For opioids, the matrix effects range was
–35.1% to –7.6% (ion suppression), with a coefficient
of variation of  28.3% (n D 4). For cannabinoids, the
matrix effects range was –14.7% to –5.8%, with a coef-
ficient of variation of  13.9% (n D 4). These results
are summarized in Tables 2 and 3.
Carryover was assessed by injecting a blank after
injection of a sample prepared at 2 000 ng/L (twice the
concentration of our highest calibrator). The results
for all target compounds for the blank were below
LOD, which means that all extracted compounds are
eluted before injection of the next sample. Autosam-
pler stability was assessed by injecting the same both
fresh and after 24 h in the autosampler at 10 C. The
mean concentrations from these injections were com-
pared to determine the percentage difference. The con-
centrations of all target compounds were within the
accepted 20%, except for oxymorphone (–21.3%).
Application to authentic samples
Samples from the East and Hudson rivers tested negative
for morphine, prescription opioids and cannabis. Sam-
ples from sewage overflows (Newtown Creek, Brooklyn)
tested positive for morphine (10.7 ng/L), oxycodone
(4.2–23.5 ng/L), oxymorphone (4.8 ng/L) and hydro-
morphone (4.2 ng/L). Raw influent wastewater samples
from the Tallman and Jamaica plants in Queens tested
positive for morphine (133.0–258.3 ng/L), oxycodone
(31.1–63.6 ng/L), oxymorphone (16.0–56.8 ng/L),
hydromorphone (6.8–18.0 ng/L), hydrocodone (4.0–
12.8 ng/L) and THCCOOH (168.2–772.0 ng/L) (Table 4).
Figure 1 shows a chromatogram of an authentic waste-
water sample that tested positive for opioids and
cannabinoids.
Discussion
We developed and validated a method for the simulta-
neous analysis of morphine, oxymorphone, oxyco-
done, hydromorphone, hydrocodone, THC and its
metabolites THCCOOH and THCOOH-glucuronide
in wastewater samples. Numerous methods for the
determination of licit and illicit drugs in wastewater
samples have been published [13–28]. These analytical
methods allow for the determination of opiates and
prescription opioids [14,18,25,27,28], cannabis [16,19]
or both classes of compounds, opiates and canna-
bis [13,15,18–20,21,22,24,26]. In the case of opiates,
most of the methods can only detect
morphine [13–15,17,18,20,21–26,28], although some
methods are suitable for prescription opioids such
as oxycodone, oxymorphone, hydrocodone and
Table 2. Inter- and intra-day imprecision and accuracy for quality controls at 10 and 100 ng/L.
Imprecision (%) Accuracy (%)
Inter-day (n D 5) Intra-day (n D 4) Inter-day (n D 5) Intra-day (n D 4)
Compound 10 (ng/L) 100 (ng/L) 10 (ng/L) 100 (ng/L) 10 (ng/L) 100 (ng/L) 10 (ng/L) 100 (ng/L)
Morphine 11.4 6.2 5.6 3.4 93.3 94.7 116.0 110.9
Oxymorphone 10.8 3.9 4.9 3.3 106.5 106.6 126.5 109.1
Hydromorphone 14.1 3.3 12.9 4.4 98.3 103.3 119.5 121.1
Oxycodone 8.9 7.6 10.9 5.0 98.3 101.1 110.0 102.0
Hydrocodone 10.0 8.8 6.1 4.8 107.5 103.7 131.0 127.2
THC 9.7 9.0 21.2 7.9 102.8 98.8 110.3 106.6
THCCOOH 8.0 6.1 5.0 7.3 97.3 105.6 119.3 103.4
THCCOOH-glucuronide 6.0 10.2 4.1 5.5 95.0 98.9 83.0 102.3
Table 3. Extraction efficiency, process efficiency, matrix effect
and coefficient of variation for each analyte at 10 ng/L.
Compound
Extraction
efficiency (%)
Process
efficiency (%)
Matrix
effect (%)
Morphine 79.0 73.3 ¡7.6
Oxymorphone 84.0 63.1 ¡24.5
Hydromorphone 75.0 48.8 ¡35.1
Oxycodone 82.0 63.5 ¡23.1
Hydrocodone 84.0 72.6 ¡13.8
THC 25.4 22.7 ¡10.6
THCCOOH 66.5 62.7 ¡5.8
THCCOOH-glucuronide 53.1 45.3 ¡14.7
Table 4. Results from raw input wastewater plants (Tallman
and Jamaica, New York City, NY) collected at one time point 1–
3 days before and after national holidays (Independence Day,
July 4 2015; Labor Day, September 7 2015; New Year’s Day,
January 1 2016) and in March 2016.
Analyte Concentration range (ng/L) N cases
Morphine 133.0 – 258.3 5
Hydrocodone 4.0 – 12.8 4
Oxycodone 31.1 – 63.6 5
Oxymorphone 16.0 – 56.8 5
Hydromorphone 6.8 – 18.0 5
THCCOOH 168.2 – 772.0 5
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hydromorphone [14,18,19,25–28]. With regard to can-
nabis, most methods have been developed for
THCCOOH [15,16,19,22,24] or for THC or THC and
THCCOOH [13,17,20,21,23,26]. There is no data
available for THCCOOH-glucuronide in wastewater
samples, even though this compound is the predomi-
nant THC metabolite in human urine [30]. This may
be because glucuronides are normally hydrolysed in
wastewater [31], resulting in higher concentrations of
the free compound. However, recent publications have
reported high concentrations of glucuronides in waste-
water samples [32,33]. These results highlight the need
for a method for detection of glucuronides in
wastewater.
Currently, the method most commonly used for
wastewater analysis is LC-MS/MS. However, gas chro-
matography-mass spectrometry has been used
too [34]. In the present method, all compounds were
ionized in positive mode (atmospheric pressure chemi-
cal/electrochemical ionization dual source), despite
other authors finding better sensitivity for cannabi-
noids in negative ionization mode (electrochemical
ionization) [13,15,21,24]. The sensitivity of our
method (LOD 1–5 ng/L and LOQ 5–10 ng/L in
100 mL of wastewater) was within the range of meth-
ods in previous publications [19,20,22,25]. Earlier
studies have reported LOQs for the compounds of
interest as low as 0.48 ng/L [35] and as high as
100 ng/L [22] for wastewater volumes between
15 mL [28] and 250 mL [17]. Sample preparation
usually involves filtration and SPE with a reversed-
phase (Oasis HLB, Waters Corp., Milford, MA, USA)
or cation exchange (Oasis MCX, Waters Corp.)
cartridges.
During method validation, matrix effect experi-
ments were carried out using four different matrices
instead of six [29]. This limitation was because it was
difficult to obtain wastewater samples that were nega-
tive for the compounds of interest. Another limitation
of the present method was the intra-day accuracy
above the established criteria for three opioids.
Although oxymorphone’s low QC, hydromorphone’s
high QC and hydrocodone’s low and high QC gave an
intra-day accuracy >120% (121.1% to 131%), the rest
of the validation parameters were within the estab-
lished range [29].
As a proof of concept, we were able to detect
THCCOOH, morphine and prescription opiates in water
samples from sewage overflow locations and wastewater
treatment plants. The concentrations of morphine (10.7–
258.3 ng/L), oxycodone (4.2–63.6 ng/L), oxymorphone
(4.8–56.8 ng/L), hydromorphone (4.2–18.0 ng/L),
hydrocodone (4.0–12.8 ng/L) and THCCOOH
(168.2–772.0 ng/L) were similar to those found in previ-
ous studies [18,19,28,29,33]. THC and THCCOOH-glu-
curonide were not detected in any of the analysed
samples. Previously, THC was detected in wastewater
samples [17], but there are no reports of the detection of
THCCOOH-glucuronide. Continued research is
required to investigate the importance of monitoring
Figure 1. Multiple reaction monitoring chromatograms of an authentic wastewater sample from Tallman Island Wastewater Treat-
ment Plant (Queens, NYC) showing positive results for THCCOOH (184.1 ng/L), morphine (181.9 ng/L), hydromorphone (10.0 ng/L),
oxymorphone (56.8 ng/L), oxycodone (63.3 ng/L) and hydrocodone (10.3 ng/L).
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THCCOOH-glucuronide’s in these types of samples, and
to back calculate the drug exposure in communities
based on wastewater drug concentrations.
Conclusion
We developed and validated an analytical method for
the simultaneous determination of morphine, common
prescription opioids (oxycodone, oxymorphone,
hydrocodone and hydromorphone), and cannabis and
its metabolites in wastewater samples. This technique
is sensitive (LOD 1–5 ng/L and LOQ 5–10 ng/L in
100 mL of sample) and specific. This is the first report
of testing for THCCOOH-glucuronide in wastewater
samples. As a proof of concept, we were able to detect
THCCOOH, morphine, and prescription opioids in
samples from sewage overflow locations and wastewa-
ter plants throughout NYC.
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